298 related articles for article (PubMed ID: 35887558)
1. Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone.
Mazzei MA; Bagnacci G; Perrella A; Di Meglio N; Piccioni SA; Bloise F; Marrelli D; Milandri C; Mura G
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887558
[TBL] [Abstract][Full Text] [Related]
2. Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on "Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone.
Kou HW; Hsu JT
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887571
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone.
Huang RY; Kou HW; Le PH; Kuo CJ; Chen TH; Wang SY; Chen JS; Yeh TS; Hsu JT
J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455672
[TBL] [Abstract][Full Text] [Related]
4. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer.
Graziosi L; Natalizi N; Donini A
J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373963
[TBL] [Abstract][Full Text] [Related]
5. Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on "Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer.
Chen YF; Le PH; Huang SC; Chou WC; Hsu JT
J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373977
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy.
Yago A; Haruta S; Ueno M; Ogawa Y; Shimoyama H; Ohkura Y; Udagawa H
World J Surg Oncol; 2022 Feb; 20(1):35. PubMed ID: 35168610
[TBL] [Abstract][Full Text] [Related]
7. Conversion surgery for gastric cancer patients: A review.
Zurleni T; Gjoni E; Altomare M; Rausei S
World J Gastrointest Oncol; 2018 Nov; 10(11):398-409. PubMed ID: 30487951
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.
Santambrogio L; Rammensee HG
Immunogenetics; 2019 Mar; 71(3):203-216. PubMed ID: 30343358
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
[TBL] [Abstract][Full Text] [Related]
10. The Aftermath of Bariatric Surgery: Can the Average Emergency Surgeon Deal with Its Complications? Comment on Zawadzka et al. Current Knowledge and Perceptions of Bariatric Surgery among Diabetologists and Internists in Poland.
Papageorgopoulou C; Nikolakopoulos K; Seretis C
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743471
[TBL] [Abstract][Full Text] [Related]
11. Conversion Surgery for Stage IV Gastric Cancer.
Zhang F; Huang X; Song Y; Gao P; Zhou C; Guo Z; Shi J; Wu Z; Wang Z
Front Oncol; 2019; 9():1158. PubMed ID: 31788445
[TBL] [Abstract][Full Text] [Related]
12. Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker.
Choe HJ; Kim JW; Han SH; Lee JH; Ahn SH; Park DJ; Kim JW; Kim YJ; Lee HS; Kim JH; Kim HH; Lee KW
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31905818
[TBL] [Abstract][Full Text] [Related]
13. Comment on Grivas et al. Morphology, Development and Deformation of the Spine in Mild and Moderate Scoliosis: Are Changes in the Spine Primary or Secondary?
de Reuver S; Schlösser TPC; Kruyt MC; Ito K; Castelein RM
J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268251
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for metastatic gastric cancer: chemotherapy, palliative surgery or radiotherapy?
Liang X; Zhu J; Li Y; Xu Y; Chen K; Lv L; Mao W
Future Oncol; 2020 Feb; 16(5):91-102. PubMed ID: 31868545
[No Abstract] [Full Text] [Related]
15. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Weigt J; Malfertheiner P
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):395-7. PubMed ID: 20678012
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
18. Comment on Zwierz et al. The Long-Term Effects of 12-Week Intranasal Steroid Therapy on Adenoid Size, Its Mucus Coverage and Otitis Media with Effusion: A Cohort Study in Preschool Children.
Kalfert D
J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407591
[TBL] [Abstract][Full Text] [Related]
19. Vinorelbine induced perforation of a metastatic gastric lesion.
Mullally WJ; O'Súilleabháin CB; Brady C; O'Reilly S
Ir J Med Sci; 2017 Aug; 186(3):571-575. PubMed ID: 28039597
[TBL] [Abstract][Full Text] [Related]
20. Conversion surgery for gastric cancer: A cohort study from a western center.
Morgagni P; Solaini L; Framarini M; Vittimberga G; Gardini A; Tringali D; Valgiusti M; Monti M; Ercolani G
Int J Surg; 2018 May; 53():360-365. PubMed ID: 29654967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
